G01N 2800/42
Poisoning
Official title: Poisoning, e.g. from bites or stings
G01N2800/42 (Poisoning) appears on 32 US grants and 52 published applications in this corpus.
Search patents in G01N- Granted patents
- 32
- Published applications
- 52
- Assignees
- 42
- Inventors
- 110
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 2 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 2 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 4 |
| 2017 | 4 | 6 |
| 2018 | 3 | 4 |
| 2019 | 4 | 3 |
| 2020 | 3 | 3 |
| 2021 | 3 | 2 |
| 2022 | 2 | 3 |
| 2023 | 1 | 3 |
| 2024 | 1 | 5 |
| 2025 | 0 | 0 |
| 2026 | 2 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- 3-phenoxybenzoic acid-glucuronic acid conjugate, and preparation method and use thereof14 Apr 2026US 12,600,741 B2Shanxi Medical University
- Methods of diagnosing or treating Lyme disease3 Mar 2026US 12,566,180 B2Drexel University
- Determining toxicity risk in CAR T-cell therapy10 Dec 2024US 12,163,952 B2Juno Therapeutics, Inc.
- Marker polypeptide of bothrops atrox-like thrombin and method thereof for detecting species source and content of snake venom-like thrombin and application20 Jun 2023US 11,680,947 B2Penglai Nuokang Pharmaceutical Co., Ltd.
- Methods for identifying risk of chemotherapy-induced cardiotoxicity and targeted medical intervention6 Dec 2022US 11,519,922 B2Detroit R&D, Inc.
- Crispr-cas-based novel guide rna capable of specific detection of norovirus gii.4 and application thereof8 Oct 2026US 2026/0308703 A1Pulmuone Co., Ltd.
- Methods of diagnosing or treating lyme disease20 Aug 2026US 2026/0243778 A1Drexel University
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Methods for detecting heavy metals in biological samples28 Nov 2024US 2024/0393322 A1The Board of Trustees of the Leland Stanford Junior University
- Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity26 Sep 2024US 2024/0316168 A1Phaim Pharma Ltd.
Most cited
By later US patents
- Therapeutic and prophylactic agents and methods of using the same16US 7,422,890 B2National University of Singapore · 2008
- Ricin ribosome binding protein compositions and methods of use thereof14US 8,895,006 B2Rutgers, The State University of New Jersey · 2014
- Methods and kit for diagnosing tick borne illnesses10US 7,390,626 B2Immunosciences Lab, Inc. · 2008
- OMPA and ASP14 in vaccine compositions and as diagnostic targets8US 9,248,174 B2Virginia Commonwealth University · 2016
- OmpA and Asp14 in vaccine compositions and as diagnostic targets4US 10,039,815 B2Virginia Commonwealth University · 2018